212 related articles for article (PubMed ID: 19553546)
1. Direct antigen presentation and gap junction mediated cross-presentation during apoptosis.
Pang B; Neijssen J; Qiao X; Janssen L; Janssen H; Lippuner C; Neefjes J
J Immunol; 2009 Jul; 183(2):1083-90. PubMed ID: 19553546
[TBL] [Abstract][Full Text] [Related]
2. Cross-presentation by intercellular peptide transfer through gap junctions.
Neijssen J; Herberts C; Drijfhout JW; Reits E; Janssen L; Neefjes J
Nature; 2005 Mar; 434(7029):83-8. PubMed ID: 15744304
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs.
Albert ML; Sauter B; Bhardwaj N
Nature; 1998 Mar; 392(6671):86-9. PubMed ID: 9510252
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells use endocytic pathway for cross-priming class Ib MHC-restricted CD8alphaalpha+TCRalphabeta+ T cells with regulatory properties.
Smith TR; Tang X; Maricic I; Garcia Z; Fanchiang S; Kumar V
J Immunol; 2009 Jun; 182(11):6959-68. PubMed ID: 19454693
[TBL] [Abstract][Full Text] [Related]
5. Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.
Klotz L; Hucke S; Thimm D; Classen S; Gaarz A; Schultze J; Edenhofer F; Kurts C; Klockgether T; Limmer A; Knolle P; Burgdorf S
J Immunol; 2009 Jul; 183(1):129-36. PubMed ID: 19535643
[TBL] [Abstract][Full Text] [Related]
6. Cross-presentation: underlying mechanisms and role in immune surveillance.
Rock KL; Shen L
Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
[TBL] [Abstract][Full Text] [Related]
7. Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles.
Keller SA; von Allmen CE; Hinton HJ; Bauer M; Muntwiler S; Dietmeier K; Saudan P; Bachmann MF
J Immunol; 2009 May; 182(10):6261-6. PubMed ID: 19414779
[TBL] [Abstract][Full Text] [Related]
8. IRAP identifies an endosomal compartment required for MHC class I cross-presentation.
Saveanu L; Carroll O; Weimershaus M; Guermonprez P; Firat E; Lindo V; Greer F; Davoust J; Kratzer R; Keller SR; Niedermann G; van Endert P
Science; 2009 Jul; 325(5937):213-7. PubMed ID: 19498108
[TBL] [Abstract][Full Text] [Related]
9. Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activity.
Brusa D; Garetto S; Chiorino G; Scatolini M; Migliore E; Camussi G; Matera L
Vaccine; 2008 Nov; 26(50):6422-32. PubMed ID: 18848858
[TBL] [Abstract][Full Text] [Related]
10. Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells.
Ackerman AL; Kyritsis C; Tampé R; Cresswell P
Nat Immunol; 2005 Jan; 6(1):107-13. PubMed ID: 15592474
[TBL] [Abstract][Full Text] [Related]
11. Efficiency of peptide presentation by dendritic cells compared with other cell types: implications for cross-priming.
Zehn D; Cohen CJ; Reiter Y; Walden P
Int Immunol; 2006 Dec; 18(12):1647-54. PubMed ID: 17035346
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of MHC class I-restricted antigen processing and cross-presentation.
Cresswell P; Ackerman AL; Giodini A; Peaper DR; Wearsch PA
Immunol Rev; 2005 Oct; 207():145-57. PubMed ID: 16181333
[TBL] [Abstract][Full Text] [Related]
13. Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications.
Wilson NS; Villadangos JA
Adv Immunol; 2005; 86():241-305. PubMed ID: 15705424
[TBL] [Abstract][Full Text] [Related]
14. Long-Peptide Cross-Presentation by Human Dendritic Cells Occurs in Vacuoles by Peptide Exchange on Nascent MHC Class I Molecules.
Ma W; Zhang Y; Vigneron N; Stroobant V; Thielemans K; van der Bruggen P; Van den Eynde BJ
J Immunol; 2016 Feb; 196(4):1711-20. PubMed ID: 26792804
[TBL] [Abstract][Full Text] [Related]
15. Gap junctions at the dendritic cell-T cell interface are key elements for antigen-dependent T cell activation.
Elgueta R; Tobar JA; Shoji KF; De Calisto J; Kalergis AM; Bono MR; Rosemblatt M; Sáez JC
J Immunol; 2009 Jul; 183(1):277-84. PubMed ID: 19542439
[TBL] [Abstract][Full Text] [Related]
16. Exiting the outside world for cross-presentation.
Rock KL
Immunity; 2006 Oct; 25(4):523-5. PubMed ID: 17046678
[TBL] [Abstract][Full Text] [Related]
17. Information sharing and collateral damage.
Li G; Herlyn M
Trends Mol Med; 2005 Aug; 11(8):350-2. PubMed ID: 16002338
[TBL] [Abstract][Full Text] [Related]
18. Gap junction-mediated intercellular communication in the immune system.
Neijssen J; Pang B; Neefjes J
Prog Biophys Mol Biol; 2007; 94(1-2):207-18. PubMed ID: 17467043
[TBL] [Abstract][Full Text] [Related]
19. Stress presents a problem for dendritic cells: corticosterone and the fate of MHC class I antigen processing and presentation.
Truckenmiller ME; Bonneau RH; Norbury CC
Brain Behav Immun; 2006 May; 20(3):210-8. PubMed ID: 16504465
[TBL] [Abstract][Full Text] [Related]
20. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]